MiMedx Quarterly Earnings Are 5% Above Earnings Guidance

On October 10, MiMedx Group, Inc. (MDMX) released its quarterly financial statements. MiMedx has third quarter revenues of $84.6 million, which was more than 5% above the company’s revenue expectations. MiMedx is a leading biopharmaceutical company specializing in regenerative and therapeutic biologics that utilize human placental tissue.


Sonal sent out an alert about the event at 6:30 am. The next trade was during pre-market hours for $12.25 before the normal market trading opened at $12.27.

The stock price continued to rise over the next four trading days as well, so there was plenty of time for investors to trade based on this event. Five trading days later, the stock price closed at $13.52. This is a return of over 10% in the five days after the event.


Visit the Knowledge Center to learn more about earnings guidance and trading on earnings events.

To see the latest weekly webinar, you can visit our Live Webinar page.

Subscribe here if you would like to start receiving these signals in real-time and start trading!